Obstructive sleep apnea/hypopnea syndrome and poor response to sertraline in patients with coronary heart disease

Journal of Clinical Psychiatry

Volumn 73, Issue 1, 2012, Pages 31-36

  Roest, Annelieke M ^a   Carney, Robert M ^b   Stein, Phyllis K ^b   Freedland, Kenneth E ^b   Meyer, Hilary ^b   Steinmeyer, Brian C ^b   De Jonge, Peter ^a,c   Rubin, Eugene H ^b  

^a TILBURG UNIVERSITY   (Netherlands)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOCOSAHEXAENOIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; LITHIUM; PLACEBO; SERTRALINE;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BODY MASS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FOLLOW UP; HAMILTON SCALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; TREATMENT DURATION; TREATMENT OUTCOME; UNITED STATES;

EID: 84856293014     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.10m06455     Document Type: Article

References (44)

1. Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med. 2004;66(6):802-813. doi:10.1097/01.psy.014632.53619.b2 PubMed (Pubitemid 39552862)
2. van Melle JP, de Jonge P, Spijkerman TA, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med. 2004;66(6):814-822. doi:10.1097/01.psy. 0146294.82810.9c PubMed (Pubitemid 39552863)
3. Berkman LF, Blumenthal J, Burg M, et al; for ENRICHD investigators. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003;289(23):3106-3116. doi:10.101/jama.289.23.3106 PubMed
4. van Melle JP, de Jonge P, Honig A, et al; MIND-IT investigators. Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry. 2007;190(6):460-466. doi:10.192/bjp.bp.106.028647 PubMed (Pubitemid 46868827)
5. Carney RM, Blumenthal JA, Freedland KE, et al; for ENRICHD investigators. Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med. 2004;66(4):466-474. doi:10.1097/01.psy.01362.75075.a6 PubMed
6. de Jonge P, Honig A, van Melle JP, et al; MIND-IT investigators. Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. Am J Psychiatry. 2007; 164(9):1371-1378. doi:10.176/api.ajp.207.06091492 PubMed (Pubitemid 47461137)
7. Carney RM, Freedland KE. Treatment-resistant depression and mortality after acute coronary syndrome. Am J Psychiatry. 2009;166(4):410-417. doi:10.176/api.ajp.208.08081239 PubMed
8. Kamholz BA, Mellow AM. Management of treatment resistance in the depressed geriatric patient. Psychiatr Clin North Am. 1996;19(2): 269-286. doi:10.1016/S0193-953X(05)7028-4 PubMed (Pubitemid 26184103)
9. Schröder CM, O'Hara R. Depression and obstructive sleep apnea (OSA). Ann Gen Psychiatry. 2005;4(1):13. doi:10.186/174-859X-4-13 PubMed
10. Szuba MP, Fernando AT, Groh-Szuba G. Sleep abnormalities in treatment-resistant mood disorders. In: Amsterdam JD, Hornig M, Nierenberg AA, eds. Treatment-Resistant Mood Disorders. Cambridge, England: Cambridge University Press; 2001:96-110. doi:10.1017/CBO9780516421.06
11. Hung J, Whitford EG, Parsons RW, et al. Association of sleep apnoea with myocardial infarction in men. Lancet. 1990;336(8710):261-264. doi:10.1016/0140-6736(90)9179-G PubMed (Pubitemid 20229120)
12. Keyl C, Lemberger P, Rödig G, et al. Changes in cardiac autonomic control during nocturnal repetitive oxygen desaturation episodes in patients with coronary artery disease. J Cardiovasc Risk. 1996;3(2):221-227. PubMed doi:10.1097/043798-196040-015
13. Schäfer H, Koehler U, Ploch T, et al. Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease. Chest. 1997;111(2):387-393. doi:10.1378/chest.1.2.387 PubMed (Pubitemid 27096956)
14. Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol. 2008;52(8):686-717. PubMed doi:10.1016/j.jac.208.05.02
15. Mooe T, Rabben T, Wiklund U, et al. Sleep-disordered breathing in women: occurrence and association with coronary artery disease. Am J Med. 1996;101(3):251-256. doi:10.1016/S02-9343(96)012-2 PubMed (Pubitemid 26392437)
16. Mooe T, Rabben T, Wiklund U, et al. Sleep-disordered breathing in men with coronary artery disease. Chest. 1996;109(3):659-663. doi:10.1378/chest.109. 3.659 PubMed (Pubitemid 26086931)
17. Wolk R, Kara T, Somers VK. Sleep-disordered breathing and cardiovascular disease. Circulation. 2003;108(1):9-12. doi:10.161/01.CIR.072346.56728.E4 PubMed (Pubitemid 36859012)
18. Butt M, Dwivedi G, Khair O, et al. Obstructive sleep apnea and cardiovascular disease. Int J Cardiol. 2010;139(1):7-16. doi:10.1016/j.ijcard. 209.05.021 PubMed
19. Guilleminault C, Connolly S, Winkle R, et al. Cyclical variation of the heart rate in sleep apnoea syndrome: mechanisms and usefulness of 24 h electrocardiography as a screening technique. Lancet. 1984;1(8369): 126-131. doi:10.1016/S0140-6736(84)9062-X PubMed (Pubitemid 14217549)
20. Stein PK, Duntley SP, Domitrovich PP, et al. A simple method to identify sleep apnea using Holter recordings. J Cardiovasc Electrophysiol. 2003; 14(5):467-473. doi:10.1046/j.1540-8167.203.0241.x PubMed (Pubitemid 36583905)
21. Kesek M, Franklin KA, Sahlin C, et al. Heart rate variability during sleep and sleep apnoea in a population based study of 387 women. Clin Physiol Funct Imaging. 2009;29(4):309-315. doi:10.1/j.1475-097X.209.0873.x PubMed
22. Carney RM, Freedland KE, Rubin EH, et al. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. JAMA. 2009;302(15):1651-1657. doi:10.101/jama.209. 1487 PubMed
23. Freedland KE, Skala JA, Carney RM, et al. The Depression Interview and Structured Hamilton (DISH): rationale, development, characteristics, and clinical validity. Psychosom Med. 2002;64(6):897-905. doi:10.1097/01.PSY.02826. 64279.29 PubMed
24. Beck AT, Steer RA, Ball R, et al. Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. J Pers Assess. 1996; 67(3):588-597. doi:10.1207/s1532752jpa6703-13 PubMed (Pubitemid 26382973)
25. Harris WS, Von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med. 2004;39(1):212-220. doi:10.1016/j.ypmed. 204.02.030 PubMed
26. Stein PK, Pu Y, Bouguerra R, et al. A comparison of automatically- detected and manually overread detection of cyclic variation of heart rate from cardiac outpatient telemetry for the identification of patients with severe sleep disorders [conference abstract]. Sleep. 2009;32:Abstract A375.
27. Beck AT, Steer RA, Brown GK. BDI-II, Beck Depression Inventory Manual. 2nd ed. San Antonio, TX: Psychological Corp; 1996.
28. Hedlund JL, Viewig BW. The Hamilton Rating Scale for Depression: a comprehensive review. J Oper Psychiatr. 1979;10:149-165.
29. Kloiber S, Ising M, Reppermund S, et al. Overweight and obesity affect treatment response in major depression. Biol Psychiatry. 2007;62(4): 321-326. doi:10.1016/j.biopsych.206.10.01 PubMed (Pubitemid 47444280)
30. Lanquillon S, Krieg JC, Bening-Abu-Shach U, et al. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology. 2000;22(4):370-379. doi:10.1016/S0893-13X(9)0134-7 PubMed (Pubitemid 30105765)
31. Harris M, Glozier N, Ratnavadivel R, et al. Obstructive sleep apnea and depression. Sleep Med Rev. 2009;13(6):437-444. doi:10.1016/j.smrv.209.04.01 PubMed
32. Damas-Mora J, Jenner FA, Sneddon J, et al. Ventilatory responses to carbon dioxide in syndromes of depression. J Psychosom Res. 1978;22(6): 473-476. doi:10.1016/02-39(78)902-8 PubMed (Pubitemid 9133897)
33. Damas-Mora J, Souster L, Jenner FA. Diminished hypercapnic drive in endogenous or severe depression. J Psychosom Res. 1982;26(2):237-245. doi:10.1016/02-39(82)9042-3 PubMed (Pubitemid 12055882)
34. Matsuo K, Onodera Y, Hamamoto T, et al. Hypofrontality and microvascular dysregulation in remitted late-onset depression assessed by functional near-infrared spectroscopy. Neuroimage. 2005;26(1):234-242. doi:10.1016/j. neuroimage.205.01.024 PubMed (Pubitemid 40602902)
35. Carney RM, Howells WB, Freedland KE, et al. Depression and obstructive sleep apnea in patients with coronary heart disease. Psychosom Med. 2006;68(3):443-448. doi:10.1097/01.psy.0204632.9178.26 PubMed (Pubitemid 44297677)
36. Carney RM, Blumenthal JA, Freedland KE, et al. Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med. 2005;165(13):1486-1491. doi:10.101/archinte.165.13.1486 PubMed (Pubitemid 41058028)
37. de Jonge P, Rosmalen JG, Kema IP, et al. Psychophysiological biomarkers explaining the association between depression and prognosis in coronary artery patients: a critical review of the literature. Neurosci Biobehav Rev. 2010;35(1):84-90. doi:10.1016/j.neubiorev.209.1.025 PubMed
38. Jelic S, Lederer DJ, Adams T, et al. Vascular inflammation in obesity and sleep apnea. Circulation. 2010;121(8):1014-1021. doi:10.161/CIRCULATIONAHA.109. 90357 PubMed
39. Sullivan CE, Issa FG, Berthon-Jones M, et al. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet. 1981;1(8225):862-865. doi:10.1016/S0140-6736(81)92140-1 PubMed (Pubitemid 11099316)
40. Bradley TD, Floras JS. Obstructive sleep apnoea and its cardiovascular consequences. Lancet. 2009;373(9657):82-93. doi:10.1016/S0140-6736(08)6162-0 PubMed
41. Punjabi NM, Caffo BS, Goodwin JL, et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. 2009;6(8):e1000132. doi:10.1371/journal.pmed.10132 PubMed
42. Fabre LF, Abuzzahab FS, Amin M, et al. Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo. Biol Psychiatry. 1995;38(9):592-602. doi:10.1016/06-323(95)0178-8 PubMed
43. Schweizer E, Rynn M, Mandos LA, et al. The antidepressant effect of sertraline is not enhanced by dose titration: results from an outpatient clinical trial. Int Clin Psychopharmacol. 2001;16(3):137-143. doi:10.1097/04850-201050-02 (Pubitemid 32402358)
44. Keller MB. Issues in treatment-resistant depression. J Clin Psychiatry. 2005;66(suppl 8):5-12. PubMed